Journal of Pharmaceutical Sciences & Emerging DrugsISSN: 2380-9477

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Michael Crider Author

Subjects of specialization
Pharmacology, Pharmaceutical Sciences, Medicinal Chemistry, Emerging Drugs, Drug Therapy

Affiliation
Professor and Chair, Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, USA

Biography

Michael Crider; Professor and Chair, Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, USA. One of his references is, "Pivonello R, De Martino MC, Cappabianca P, De Leo M, Faggiano A, et al. (2009) The medical treatment of Cushing’s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J Clin Endocrinol Metab 94: 223-230."


Publications

Editorial Open Access

Pituitary-Directed Drug Therapy for the Treatment of Cushing's Disease

Author(s):

Michael Crider

Pituitary-Directed Drug Therapy for the Treatment of Cushing’s Disease

Cushing’s disease (CD) is usually the result of an adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma. The result is overstimulation of the adrenal glands leading to chronic hypercortisolism. Individuals with CD have increased risks of hypertension, obesity, hyperglycemia, infections, and vascular damage. Transsphenoidal surgery of the pituitary adenoma is the preferred o... view moreĀ»

DOI: 10.4172/2380-9477.1000e103

Abstract HTML PDF



Social Media


Google Scholars / Researchers Sites

GET THE APP